Rezolute Inc Stock Ownership - Who owns Rezolute?


Insider buying vs selling

Have Rezolute Inc insiders been buying or selling?
Brian Kenneth RobertsSr VP Clinic Development2022-05-19300$2.95
Brian Kenneth RobertsSr VP Clinic Development2022-05-18200$2.86
Brian Kenneth RobertsSr VP Clinic Development2022-05-171,000$3.41
Gil M. LabrucherieDirector2022-05-0452,631$3.80
Brian Kenneth RobertsSr VP Clinic Development2022-05-0421,052$3.80
Gil M. LabrucherieDirector2022-05-0452,631$3.80
Wladimir HogenhuisDirector2022-05-0425,000$3.80
Gil M. LabrucherieDirector2022-05-0452,631$3.80
Wladimir HogenhuisDirector2021-10-157,693$6.50

1 of 1

RZLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RZLT insiders and whales buy or sell their stock.

RZLT Shareholders

What type of owners hold Rezolute Inc stock?
Genexine Inc235.14%91,300,933$269.34MInsider
Federated Hermes Inc17.02%6,610,274$19.50MInstitution
Stonepine Capital Management LLC7.73%3,001,926$8.86MInstitution
First Manhattan Co4.68%1,815,805$5.36MInstitution
Blackstone Inc3.96%1,537,684$4.54MInstitution
Vanguard Group Inc3.62%1,407,131$4.15MInstitution
Caxton Corp3.61%1,403,157$4.14MInstitution
Janus Henderson Group PLC3.12%1,210,000$3.57MInstitution
Commodore Capital LP3.12%1,210,000$3.57MInstitution
Sphera Funds Management Ltd2.98%1,155,897$3.41MInstitution

1 of 3

RZLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RZLT21.16%78.84%Net Buying
SEEL29.36%53.52%Net Buying
ANVS9.44%32.11%Net Buying
PBYI57.88%42.12%Net BuyingNet Selling

Rezolute Stock Ownership FAQ

Who owns Rezolute?

Rezolute (NASDAQ: RZLT) is owned by 63.20% institutional shareholders, 235.54% Rezolute insiders, and 0.00% retail investors. Genexine Inc is the largest individual Rezolute shareholder, owning 91.30M shares representing 235.14% of the company. Genexine Inc's Rezolute shares are currently valued at $257.47M.

If you're new to stock investing, here's how to buy Rezolute stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.